SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-24-000104
Filing Date
2024-08-09
Accepted
2024-08-09 07:01:05
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20240630.htm   iXBRL 10-Q 1053449
2 EX-31.1 kprx-20240630xexx311.htm EX-31.1 7433
3 EX-31.2 kprx-20240630xexx312.htm EX-31.2 7458
4 EX-32.1 kprx-20240630xexx321.htm EX-32.1 3840
5 EX-32.2 kprx-20240630xexx322.htm EX-32.2 3854
  Complete submission text file 0001372514-24-000104.txt   6745495

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240630.xsd EX-101.SCH 53465
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20240630_cal.xml EX-101.CAL 70180
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20240630_def.xml EX-101.DEF 271355
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240630_lab.xml EX-101.LAB 717501
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240630_pre.xml EX-101.PRE 476148
70 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240630_htm.xml XML 815085
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 241190366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)